Can a daily pill and a simple physical therapy delay moyamoya strokes?
NCT ID NCT07762547
First seen Aug 13, 2026 · Last updated Aug 14, 2026 · Updated 1 time
Summary
This trial tests whether aspirin and a non-invasive physical therapy called ischemic conditioning can slow the progression of moyamoya disease, a rare brain vessel disorder that can cause strokes and cognitive decline. The study enrolls adults with moyamoya disease or syndrome who have not had a major stroke, and compares these treatments against placebos over one year. The goal is to see if these approaches can prevent disease progression and reduce the risk of cerebrovascular events like transient ischemic attacks and strokes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- aspirin and remote ischemic conditioning
- What this could lead to
- If effective, this could establish a non-surgical treatment to slow moyamoya disease and reduce stroke risk, offering an alternative for patients who cannot or prefer not to have surgery.
- What could go wrong
- The trial is early and results are not yet known. Aspirin may increase bleeding risk, and ischemic conditioning may not provide benefit in this specific condition.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASPIRIN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Beijing Tiantan Hospital, Capital Medical University
Beijing, Beijing Municipality, 100000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple aspirin pill replace daily shots to prevent postpartum blood clots?
- Metaverse meets microsurgery: XR platform aims to sharpen brain bypass precision
- French biobank aims to unlock secrets of rare brain vessel diseases
- Could LVAD patients ditch aspirin? new trial aims to find out
- Your digital twin could help prevent another stroke
- Could a simple MRI and blood test predict moyamoya before it strikes?